Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Recommendations

ASCO and the SSO developed the following recommendations on the use of SNB and lymph node dissection for melanoma:

  • SNB is recommended for patients with a melanoma that developed on any part of the surface of the skin and is 1 millimeter (mm) to 4 mm thick.
  • SNB may be recommended to help stage and determine treatment for a melanoma that is thicker than 4 mm.
  • SNB is not recommended for most patients with a thin melanoma (less than 1 mm thick), although it may be considered if the melanoma has a high risk of spreading. It is not yet certain which patients with a thin melanoma have a higher risk of the disease spreading to the lymph nodes. However, some high-risk features of melanoma include ulceration (the outer layer of skin over the melanoma is missing when viewed under a microscope) or a high mitotic rate (more cells that are dividing; a sign that the cancer may be growing rapidly).

A lymph node dissection is recommended for all patients when melanoma is found in the sentinel lymph nodes.

© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.